Fig. 3From: Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopyCourse of serum aldosterone concentration (a) and plasma renin activity (b) under treatment with SGLT2 inhibitors. Left side shows absolute values, right side shows values normalized for baseline value. Whiskers indicate median and interquartile range. Friedman test was performed to test for significant differences during course of follow up; Wilcoxon Signed-Rank test was used to evaluate for differences between respective points of follow up; Bonferroni correction for multiple testing was performedBack to article page